Funding for this research was provided by:
National Institutes of Health (P30DK092924, T32-HP19025)
Received: 19 August 2020
Accepted: 24 June 2021
First Online: 5 July 2021
: The research protocol and need to consent was exempted after review by University of California San Francisco’s Human Research Protection Program Institutional Review Board under the category that the research involved existing data that did not allow identification of subjects, directly or through identifiers linked to the subjects. Solera Health obtained internal approval and provided the de-identified data for this analysis; as such, it is not considered human subjects research and was exempt.
: Not applicable.
: BC and SW are employees of Solera Health and SW is an equity holder in Solera Health. The remaining authors do not have competing interests to declare.